The utility of PAX8 and IMP3 immunohistochemical stains in the differential diagnosis of benign, premalignant, and malignant endocervical glandular lesions.

[1]  G. Sauter,et al.  Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck. , 2013, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[2]  N. Ordóñez.  Value of PAX 8 Immunostaining in Tumor Diagnosis: A Review and Update , 2012, Advances in anatomic pathology.

[3]  G. Kristiansen,et al.  Insulin‐like growth factor II mRNA‐binding protein 3 (IMP3) expression in hepatocellular carcinoma. A clinicopathological analysis with emphasis on diagnostic value , 2012, Histopathology.

[4]  K. Rock,et al.  IMP3, a New Biomarker to Predict Progression of Cervical Intraepithelial Neoplasia Into Invasive Cancer , 2011, The American journal of surgical pathology.

[5]  A. Krasinskas,et al.  NY-BR-1 and PAX8 immunoreactivity in breast, gynecologic tract, and other CK7+ carcinomas: potential use for determining site of origin. , 2011, American journal of clinical pathology.

[6]  Jason D. Wright,et al.  Pax8: A marker for carcinoma of Müllerian origin in serous effusions , 2011, Diagnostic Cytopathology.

[7]  Liang Cheng,et al.  Expression of PAX8 in Normal and Neoplastic Tissues: A Comprehensive Immunohistochemical Study , 2011, Applied immunohistochemistry & molecular morphology : AIMM.

[8]  L. Truong,et al.  PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study , 2011, Modern Pathology.

[9]  M. Loda,et al.  A Comprehensive Analysis of PAX8 Expression in Human Epithelial Tumors , 2011, The American journal of surgical pathology.

[10]  M. Prasad,et al.  IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype. , 2009, Human pathology.

[11]  Jun Xia,et al.  IMP3 Is a Novel Prognostic Marker that Correlates with Colon Cancer Progression and Pathogenesis , 2009, Annals of Surgical Oncology.

[12]  R. Yantiss,et al.  Use of IMP3 in Identification of Carcinoma in Fine Needle Aspiration Biopsies of Pancreas , 2008, Acta Cytologica.

[13]  K. Rock,et al.  IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16INK4a expression , 2007, Modern Pathology.

[14]  H. Yee,et al.  Utility of p16INK4a, CEA, Ki67, P53 and ER/PR in the Differential Diagnosis of Benign, Premalignant, and Malignant Glandular Lesions of the Uterine Cervix and Their Relationship with Silverberg Scoring System for Endocervical Glandular Lesions , 2007, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[15]  W. McCluggage,et al.  Endocervical glandular lesions: controversial aspects and ancillary techniques , 2003, Journal of clinical pathology.

[16]  M. Nucci.  Symposium part III: tumor-like glandular lesions of the uterine cervix. , 2002, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[17]  E. Pirog,et al.  Proliferative Activity of Benign and Neoplastic Endocervical Epithelium and Correlation with HPV DNA Detection , 2002, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[18]  W. McCluggage,et al.  Glandular lesions of the uterine cervix , 2000 .

[19]  R. Kurman,et al.  Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[20]  L. D. A. de Ângelo Andrade,et al.  Endocervical tubal metaplasia and adenocarcinoma in situ: role of immunohistochemistry for carcinoembryonic antigen and vimentin in differential diagnosis , 1996, Histopathology.